The LEADER trial showed a significant reduction in MACE and cardiovascular mortality with liraglutide [14]
Prospective studies will be needed to determine whether semaglutide truly increases the risk of NAION, and whether certain formulations, doses, or patient groups are particularly vulnerable
Is there clinical evidence that GLP-1 medications harm fetal development
Ill give you my perspective, make connections Im certain nobody else has made, and Ill even share a microdosing experiment Im runningand what Ive experienced myself
DrSkin Med Spas team can offer support and guidance throughout your weight loss journey, helping you navigate potential challenges and celebrate your successes
Comparison factors include monthly pricing, clinical support level, pharmacy partner reputation, customer service responsiveness, and availability in your state